Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy
Authors:
- Constantinos O’mAhonyCOConstantinos O’mAhony
- Fatima JichiFJFatima Jichi
- Lorenzo MonserratLMLorenzo Monserrat
- Martin Ortiz-GengaMOMartin Ortiz-Genga
- Aristides AnastasakisAAAristides Anastasakis
- Claudio RapezziCRClaudio Rapezzi
- Elena BiaginiEBElena Biagini
- Juan Ramon GimenoJuan Ramon Gimeno
- Giuseppe LimongelliGiuseppe Limongelli
- William J. McKennaWMWilliam J. McKenna
- Rumana Z. OmarRORumana Z. Omar
- Perry M. ElliottPerry M. Elliott
Open Access
- 1 June 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 9 (6) , e003818
Abstract
Background—Hypertrophic cardiomyopathy is associated with sudden cardiac death (SCD). Some studies have shown an association between risk of sudden death and left ventricular maximal wall thickness (MWT), but there are few data in patients with extreme hypertrophy. The aim of this study was to determine the relation between MWT and the risk of SCD. Methods and Results—This is a multicenter, retrospective, longitudinal cohort study of 3673 adult (≥16 years) patients, previously used to develop and validate a risk prediction model for SCD (HCM Risk-SCD [hypertrophic cardiomyopathy risk-SCD]). There was an inverted U-shaped relation between MWT and the estimated 5-year risk of SCD. In patients with MWT≥35 mm (n=47; mean age, 33 years; 81% men), there was a single SCD end point (annual rate, 0.2%; 95% confidence interval, 0.03–1.60) and 3 additional cardiovascular events during a median follow-up of 9.5 years. Compared with patients with MWT≤14 mm, those with MWT≥35 mm did not have a higher risk for SCD (hazard ratio, 0.22; 95% confidence interval, 0.03–1.65), cardiovascular death (hazard ratio, 0.66; 95% confidence interval, 0.26–1.67), or all-cause mortality (hazard ratio, 0.73; 95% confidence interval, 0.32–1.69). Conclusions—The risk of SCD has a complex, nonlinear relationship to MWT. The pathophysiological mechanisms behind this observation require further study but implantable cardioverter defibrillator implantation should not be guided solely on the severity of left ventricular hypertrophy.Keywords
This publication has 33 references indexed in Scilit:
- Relationship of Delayed Enhancement by Magnetic Resonance to Myocardial Perfusion by Positron Emission Tomography in Hypertrophic CardiomyopathyCirculation: Cardiovascular Imaging, 2013
- Left Ventricular Outflow Tract Obstruction as a Risk Factor for Sudden Cardiac Death in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2009
- Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathyEuropean Heart Journal, 2009
- Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patientsJournal of Molecular and Cellular Cardiology, 2008
- The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptomsJACC, 2005
- Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathyJACC, 2004
- Hypertrophic CardiomyopathyCirculation, 2003
- Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2000
- A biological approach to sudden cardiac death: Structure, function and causeThe American Journal of Cardiology, 1989
- Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: Functional and morphologic features and clinical significanceJACC, 1986